Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice

Active, not recruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

August 27, 2024

Study Completion Date

December 31, 2028

Conditions
Coronary Artery DiseaseCoronary Disease
Interventions
DEVICE

Xience Sierra stent

Percutaneous coronary intervention with Xience Sierra stent

Trial Locations (10)

Unknown

Dong-A Medical Center, Busan

Inje University Busan Paik Hospital, Busan

Gangwon National Univ. Hospital, Chuncheon

Keimyung University Dongsan Medical Center, Daegu

Gangneung Asan Hospital, Gangneung

Asan Medical Center, Seoul

The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul

The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul

St.carollo Hospital, Suncheon

Wonju Severance Christian Hospital, Wŏnju

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

lead

Seung-Jung Park

OTHER

NCT03967158 - Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice | Biotech Hunter | Biotech Hunter